News
New designer proteins created using an AI tool can selectively target peptide segments that bind to markers on diseased ...
Researchers have discovered a way to make the immune system's T cells significantly more effective at fighting cancer. By ...
AstraZeneca has dropped the lead candidate from its $200 million buyout of Neogene Therapeutics as part of a wider cell ...
A new AI tool that models how variations in peptides change T cell receptor binding could help design immunotherapies with ...
Imagine your immune cells could be modified to attack any kind of cancer. T cell receptor (TCR) therapy has the potential to ...
Janssen’s drug JNJ-68284528 is currently being evaluated for the treatment of CAR T-Cell Therapy for Multiple Myeloma. The ...
In fighting chronic infections or certain cancers, CD8+ T cells—the immune system's frontline soldiers—eventually become ...
Scientists have developed a hydrogel “rest stop” that shields cancer-fighting T cells, delaying their exhaustion and boosting ...
He made a conceptual leap in immunotherapy by creating a hybrid T-cell, known as CAR-T, that was genetically modified to ...
Investigators led by Navdeep Chandel, Ph.D., the David W. Cugell, MD, Professor of Medicine in the Division of Pulmonary and ...
T Cells Might Be Our Bodies’ Best Shot Against Omicron The new variant may undermine some vaccine-derived defenses. But the immune system’s best assassins are likely to hold the line.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results